Brief: NGM Reports First Quarter 2022 Financial Results
05/05/2022 22:33
May 5 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS FIRST
QUARTER
2022 FINANCIAL RESULTS
* NGM BIOPHARMACEUTICALS - QTRLY LOSS PER SHARE $0.42
* CASH, CASH EQUIVALENTS AND SHORT-TERM MARKETABLE
SECURITIES WERE
$329.8 MILLION AS OF MARCH 31, 2022
* Q1 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8jmvb3
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors